Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis

被引:38
作者
Flynn, JC
McCormick, DJ
Brusic, V
Wan, Q
Panos, JC
Giraldo, AA
David, CS
Kong, YCM [1 ]
机构
[1] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA
[2] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
[3] Inst Infocomm Res, Singapore 119613, Singapore
[4] St Johns Hosp, Div Immunopathol, Detroit, MI 48236 USA
[5] Wayne State Univ, Med Ctr, Detroit, MI 48236 USA
关键词
autoimmune thyroiditis; HLA-DR3; transgene; thyroglobulin; DR3-binding peptide;
D O I
10.1016/j.cellimm.2004.07.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
To identify pathogenic epitopes on human thyroglobulin (hTg), a homodimer of 660kDa, we have applied a computer-based algorithm to predict potential HLA-DR3-binding peptides and have tested them in DR3-transgenic mice. Of the 39 peptides selected, four stimulated a proliferative response from hTg-primed cells of DR3(+) mice, but not DQ8(+) mice. Of the four peptides, one, hTg2079, was consistently pathogenic. Thyroiditis was not only produced by adoptive transfer of hTg-primed, hTg2079-activated cells but also by direct immunization with the peptide. These results demonstrate the utility of using this computer-based algorithm with synthetic peptides to help identify pathogenic T cell epitopes on hTg. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 27 条
[1]
NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice [J].
Abraham, RS ;
Wilson, SB ;
de Souza, NF ;
Strominger, JL ;
Munn, SR ;
David, CS .
HUMAN IMMUNOLOGY, 1999, 60 (07) :583-590
[2]
Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model [J].
Abraham, RS ;
Wen, L ;
Marietta, EV ;
David, CS .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1370-1379
[3]
Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease [J].
Ban, Y ;
Greenberg, DA ;
Concepcion, E ;
Skrabanek, L ;
Villanueva, R ;
Tomer, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15119-15124
[4]
REGULATION OF EXPERIMENTAL AUTOIMMUNE-THYROIDITIS - MAPPING OF SUSCEPTIBILITY TO THE I-A SUBREGION OF THE MOUSE H-2 [J].
BEISEL, KW ;
DAVID, CS ;
GIRALDO, AA ;
KONG, YM ;
ROSE, NR .
IMMUNOGENETICS, 1982, 15 (04) :427-430
[5]
MHCPEP, a database of MHC-binding peptides: update 1997 [J].
Brusic, V ;
Rudy, G ;
Harrison, LC .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :368-371
[6]
Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding [J].
Brusic, V ;
Bucci, K ;
Schönbach, C ;
Petrovsky, N ;
Zeleznikow, J ;
Kazura, JW .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2001, 19 (05) :405-+
[7]
CARAYANNIOTIS G, 1994, IMMUNOGENETICS, V39, P21, DOI 10.1007/BF00171793
[8]
Carayanniotis G, 2000, Int Rev Immunol, V19, P557
[9]
Cloning and characterization of murine thyroglobulin cDNA [J].
Caturegli, P ;
Vidalain, PO ;
Vali, M ;
AguileraGalaviz, LA ;
Rose, NR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (02) :221-226
[10]
MICE LACKING MHC CLASS-II MOLECULES [J].
COSGROVE, D ;
GRAY, D ;
DIERICH, A ;
KAUFMAN, J ;
LEMEUR, M ;
BENOIST, C ;
MATHIS, D .
CELL, 1991, 66 (05) :1051-1066